Biogen (BIIB) A Roadmap...

NASDAQ:BIIB   Biogen Inc
BIIB came out a nice Gartley Pattern on 4/22.

First stop should be the $277 area as AB=CD , where I would think there will be some profit taking.

Upside targets ($290+) are shown as this evolves into a possible Deep Crab Harmonic Pattern .

Biogen needs FDA drug approval, descent earning against healthy market backdrop for this to happen.

In higher time-frames you may also have a cup and handle formation.

As usual do your own DD

Comment: An update...
Comment: Biogen rallied to our $277+ level and backed off as expected.

It would not surprise me to see some consolidation here and then and run up to the upper D level provided we remain in a healthy broad market

Comment: Acting quite well..